Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bringing COPD rehab home: a lifeline for those left out

NCT ID NCT05664945

Symptom relief Sponsor: Copenhagen University Hospital, Hvidovre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two new types of pulmonary rehabilitation—home-based and tele-rehabilitation—for people with COPD who cannot attend standard hospital or community programs. The goal is to see if these options are better than usual care (medication and check-ups) at reducing symptoms and improving daily life. About 180 participants will be followed for several months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Indication for pulmonary rehabilitation according to Danish national guidelines * Unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation * A post-bronchodilator ratio FEV1/FVC \<70% (confirmed physician diagnosis of COPD) * A post-bronchodilator FEV1 \<80% (degree of airway obstruction) corresponding to GOLD grade 2-4 (moderate to very severe) * GOLD group B, C, D corresponding to severe respiratory symptoms and/or frequent acute exacerbations * Able to stand up from a chair (height 44-46cm) and walk 10 meters independently (with or without a walking aid) * Able to lift both arms to a horizontal level with a minimum of 1 kilogram's dumbbells in each hand Exclusion Criteria: * Participation in conventional PR in the past 24 months * Cognitive impairment - unable to follow instructions * Impaired hearing or vision - unable to see or hear instruction from a tablet * Unable to understand and speak Danish * Comorbidities where the exercise content is contraindicated (e.g. treatment for diabetic foot ulcer, active cancer treatment, life expectancy \<12-months)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease

Contacts and locations

Locations

  • Bornholms Hospital

    Rønne, 3700, Denmark

  • Copenhagen University Hospital Amager

    Copenhagen, Greater Copenhagen, 2300, Denmark

  • Copenhagen University Hospital Bispebjerg-Frederiksberg

    Copenhagen, Greater Copenhagen, 2400, Denmark

  • Copenhagen University Hospital Herlve-Gentofte

    Gentofte Municipality, Greater Copenhagen, 2820, Denmark

  • Copenhagen University Hospital Hvidovre

    Hvidovre, Greater Copenhagen, 2650, Denmark

  • Copenhagen University Hospital Nordsjaelland

    Hillerød, Greater Copenhagen, 3400, Denmark

  • Municipality of Copenhagen

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.